Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In the context of, dasatinib is approved by the FDA for adults with Acute Lymphoblastic Leukemia (ALL) (Ph+ ALL) with resistance or intolerance to prior therapy (including prior tyrosine kinase inhibitors) (1).
The EMA approves dasatinib for adults with Acute Lymphoblastic Leukemia (ALL) (Ph+ ALL) who have resistance or intolerance to prior therapy, typically after imatinib failure.
see (2)
(1) [fda-approves-generi…